PT Cipta Sarana Medika Tbk (IDX:DKHH)
Indonesia
· Delayed Price · Currency is IDR 75.00
0.00 (0.00%)
Last updated: Apr 29, 2026, 2:50 PM WIB
IDX:DKHH Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 144,873 | 152,142 | 134,188 | 99,578 | 105,656 |
| Revenue Growth (YoY) | -4.78% | 13.38% | 34.76% | -5.75% | - |
| Cost of Revenue | 111,927 | 106,856 | 91,669 | 70,105 | 69,119 |
| Gross Profit | 32,946 | 45,286 | 42,519 | 29,473 | 36,537 |
| Selling, General & Admin | 29,496 | 33,975 | 26,606 | 19,131 | 19,129 |
| Other Operating Expenses | - | - | 2,871 | 174.06 | 415.02 |
| Operating Expenses | 29,496 | 33,975 | 32,845 | 22,327 | 22,499 |
| Operating Income | 3,451 | 11,311 | 9,674 | 7,146 | 14,038 |
| Interest Expense | -10,242 | -11,556 | -7,223 | -3,512 | -4,618 |
| Interest & Investment Income | 13,191 | - | - | - | - |
| Other Non Operating Income (Expenses) | 682.23 | 411.33 | -267.52 | 1,072 | 784.19 |
| EBT Excluding Unusual Items | 7,081 | 166.88 | 2,184 | 4,706 | 10,205 |
| Gain (Loss) on Sale of Assets | -1,392 | -97.38 | - | 23.05 | - |
| Other Unusual Items | - | 3,248 | 3,032 | 1,379 | - |
| Pretax Income | 5,689 | 3,318 | 5,215 | 6,108 | 10,205 |
| Income Tax Expense | -332.96 | 480.37 | 1,676 | 1,220 | 2,304 |
| Earnings From Continuing Operations | 6,022 | 2,837 | 3,540 | 4,888 | 7,901 |
| Minority Interest in Earnings | -0.25 | -0.13 | - | - | - |
| Net Income | 6,022 | 2,837 | 3,540 | 4,888 | 7,901 |
| Net Income to Common | 6,022 | 2,837 | 3,540 | 4,888 | 7,901 |
| Net Income Growth | 112.24% | -19.85% | -27.59% | -38.13% | - |
| Shares Outstanding (Basic) | 2,364 | 800 | 555 | 555 | 309 |
| Shares Outstanding (Diluted) | 2,364 | 800 | 555 | 555 | 309 |
| Shares Change (YoY) | 195.43% | 44.27% | - | 79.52% | - |
| EPS (Basic) | 2.55 | 3.55 | 6.38 | 8.81 | 25.57 |
| EPS (Diluted) | 2.55 | 3.55 | 6.38 | 8.81 | 25.57 |
| EPS Growth | -28.16% | -44.44% | -27.59% | -65.54% | - |
| Free Cash Flow | -21,823 | -21,450 | -16,411 | -9,247 | 22,887 |
| Free Cash Flow Per Share | -9.23 | -26.80 | -29.59 | -16.67 | 74.07 |
| Gross Margin | 22.74% | 29.77% | 31.69% | 29.60% | 34.58% |
| Operating Margin | 2.38% | 7.43% | 7.21% | 7.18% | 13.29% |
| Profit Margin | 4.16% | 1.86% | 2.64% | 4.91% | 7.48% |
| Free Cash Flow Margin | -15.06% | -14.10% | -12.23% | -9.29% | 21.66% |
| EBITDA | 15,448 | 20,391 | 17,429 | 15,483 | 19,863 |
| EBITDA Margin | 10.66% | 13.40% | 12.99% | 15.55% | 18.80% |
| D&A For EBITDA | 11,997 | 9,080 | 7,755 | 8,337 | 5,825 |
| EBIT | 3,451 | 11,311 | 9,674 | 7,146 | 14,038 |
| EBIT Margin | 2.38% | 7.43% | 7.21% | 7.18% | 13.29% |
| Effective Tax Rate | - | 14.48% | 32.13% | 19.97% | 22.58% |
Source: S&P Capital IQ. Standard template. Financial Sources.